Immunological role of prostaglandin E2 production in mouse auditory cells in response to LPS

Innate Immunity

Volumn 20, Issue 6, 2014, Pages 639-646

  Tanigawa, Tohru ^a   Odkhuu, Erdenezaya ^a   Morikawa, Akiko ^a   Hayashi, Ken ^b   Sato, Takashi ^c   Shibata, Rei ^d   Goto, Fumiyuki ^e   Ueda, Hiromi ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shinkawa Clinic   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Auditory cells; Cyclooxygenase; HEI OC1 cells; Lipopolysaccharide; Prostaglandin E2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BACTERIUM LIPOPOLYSACCHARIDE; CPG OLIGODEOXYNUCLEOTIDE; CYCLOOXYGENASE 2; CYTOKINE; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PAM3CSK4; POLYINOSINIC POLYCYTIDYLIC ACID; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; IL1B PROTEIN, MOUSE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PTGS2 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

ACOUSTIC NERVE FIBER; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HEI OC1 CELL LINE; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; COCHLEA; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; AUDITORY CELL; CELL TYPE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; COCHLEA; CYCLOOXYGENASE 2; DINOPROSTONE; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84907052399     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913503578     Document Type: Article

References (27)

1. Legler DF, Bruckner M, Uetz-von Allmen E and Krause P. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 2010; 42: 198-201.
2. Nakagawa T. Roles of prostaglandin E2 in the cochlea. Hear Res 2011; 276: 27-33.
3. Sugimoto Y and Narumiya S. Prostaglandin E receptors. J Biol Chem 2007; 282: 11613-11617.
4. Andreasson K. Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 2010; 91: 104-112.
5. Hori R, Nakagawa T, Sugimoto Y, Sakamoto T, Yamamoto N, Hamaguchi K and Ito J. Prostaglandin E receptor subtype EP4 agonist protects auditory hair cells against noise-induced trauma. Neuroscience 2009; 160: 813-819.
6. Hori R, Nakagawa T, Yamamoto N, Hamaguchi K and Ito J. Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear. BMC Neurosci 2010; 11: 35.
7. Stjernschantz J, Wentzel P and Rask-Andersen H. Localization of prostanoid receptors and cyclo-oxygenase enzymes in guinea pig and human cochlea. Hear Res 2004; 197: 65-73.
8. Ziegler EA, Brieger J, Heinrich UR and Mann WJ. Immunohistochemical localization of cyclooxygenase isoforms in the organ of corti and the spiral ganglion cells of guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec 2004; 66: 297-301.
9. Kawata R, Urade Y, Tachibana M and Mizukoshi O. Prostaglandin synthesis by the cochlea. Prostaglandins 1988; 35: 173-184.
10. Tanigawa T, Morikawa A, Hayashi K, Dan K, Tsuchihashi N, Goto F, et al. Auditory cells produce nitric oxide in response to bacterial lipopolysaccharide. Innate Immun 2013; 19: 115-120.
11. Kalinec GM, Webster P, Lim DJ and Kalinec F. A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol Neurootol 2003; 8: 177-189.
12. Towbin H, Staehelin T and Gordon J. Electrophoretic transfer of proteins from plyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350-4354.
13. Morikawa A, Koide N, Kato Y, Sugiyama T, Chakravortty D, Yoshida T, et al. Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun 2000; 68: 6209-6214.
14. Terashima T, Haque A, Kajita Y, Takeuchi A, Nakagawa T and Yokochi T. Flavopiridol inhibits interferon-g-induced nitric oxide production in mouse vascular endothelial cells. Immunol Lett 2012; 148: 91-96.
15. Haque A, Koide N, Odkhuu E, Tsolmongyn B, Naiki Y, Komatsu T, et al. Mouse pyrin and HIN domain family member 1 (pyhin1) protein positively regulates lipopolysaccharide- induced interferon-beta and nitric oxide production in macrophages. Innate Immun 2014; 20: 40-48.
16. Odkhuu E, Koide N, Haque A, Tsolmongyn B, Naiki Y, Hashimoto S, et al. Inhibition of receptor activator of nuclear factor-kB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ). Immunol Lett 2012; 142: 34-40.
17. Mendjargal A, Odkhuu E, Koide N, Nagata H, Kurokawa T, Nonami T and Yokochi T. Pifithrin-a, a pharmacological inhibitor of p53, downregulates lipopolysaccharide-induced nitric oxide production via impairment of the MyD88-independent pathway. Int Immunopharmacol 2013; 15: 671-678.
18. Dayer JM, Beutler B and Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985; 162: 2163-2168.
19. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-1450.
20. Davies P, Bailey PJ, Goldenberg MM and Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol 1984; 2: 335-257.
21. Harris SG, Padilla J, Koumas L, Ray D and Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 144-150.
22. Simmons DL, Botting RM and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56: 387-437.
23. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG and Needelman P. Nitric oxide activates cyclooxygenase enzymes. Pro Natl Acad Sci U S A 1993; 90: 7240-7244.
24. Guan Z, Buckman SY, Pentland AP, Templeton DJ and Morrison AR. Induction of cyclooxygenase-2 by the activated MEKK1 ! SEK1/MKK4 ! p38 mitogen-activated protein kinase pathway. J Biol Chem 1998; 273: 12901-12908.
25. Guan Z, Buckman SY, Miller BW, Springer LD and Morrison AR. Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 1998; 273: 28670-28676.
26. Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, et al. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharidestimulated monocytes. J Immunol 1998; 161: 5681-5686.
27. DAcquisto F, Iuvone T, Rombolà L, Sautebin L, Di Rosa M and Carnuccio R. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 1997; 418: 175-178.